Published in Cancer Weekly, November 1st, 2005
Vion had previously announced the execution of a research collaboration and option agreement with the inventors and aws in December 2003. During the period of this agreement, Vion evaluated several compounds in preclinical studies and determined to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.